Works matching IS 0344-5704 AND VI 74 AND IP 2 AND DT 2014
Results: 27
Frontline treatment with gemcitabine, oxaliplatin and erlotinib for the treatment of advanced or metastatic pancreatic cancer: a multicenter phase II study of the Hellenic Oncology Research Group (HORG)
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Novel DNA methyltransferase-1 (DNMT1) depleting anticancer nucleosides, 4'-thio-2'-deoxycytidine and 5-aza-4'-thio-2'-deoxycytidine.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Third-space fluid distribution of pemetrexed in non-small cell lung cancer patients.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 2, p. 349, doi. 10.1007/s00280-014-2485-x
- By:
- Publication type:
- Article
Phase 1 dose-escalation study of the PARP inhibitor CEP-9722 as monotherapy or in combination with temozolomide in patients with solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 2, p. 257, doi. 10.1007/s00280-014-2486-9
- By:
- Publication type:
- Article
Cimetidine attenuates vinorelbine-induced phlebitis in mice by militating E-selectin expression.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 2, p. 239, doi. 10.1007/s00280-014-2487-8
- By:
- Publication type:
- Article
Gastric cancer with para-aortic lymph node metastases: do not miss a chance of cure!
- Published in:
- 2014
- By:
- Publication type:
- Letter
A phase II study of metronomic paclitaxel/cyclophosphamide/capecitabine followed by 5-fluorouracil/epirubicin/cyclophosphamide as preoperative chemotherapy for triple-negative or low hormone receptor expressing/HER2-negative primary breast cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 2, p. 229, doi. 10.1007/s00280-014-2492-y
- By:
- Publication type:
- Article
A phase I study of pegylated liposomal doxorubicin and temsirolimus in patients with refractory solid malignancies.
- Published in:
- 2014
- By:
- Publication type:
- Report
Role of pregnane X receptor in chemotherapeutic treatment.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 2, p. 217, doi. 10.1007/s00280-014-2494-9
- By:
- Publication type:
- Article
Differential regulation of bladder cancer growth by various glucocorticoids: corticosterone and prednisone inhibit cell invasion without promoting cell proliferation or reducing cisplatin cytotoxicity.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 2, p. 249, doi. 10.1007/s00280-014-2496-7
- By:
- Publication type:
- Article
Supplementation of fish oil augments efficacy and attenuates toxicity of 5-fluorouracil in 1,2-dimethylhydrazine dihydrochloride/dextran sulfate sodium-induced colon carcinogenesis.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 2, p. 309, doi. 10.1007/s00280-014-2497-6
- By:
- Publication type:
- Article
A phase II trial of Cremorphor EL-free paclitaxel (Genexol-PM) and gemcitabine in patients with advanced non-small cell lung cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 2, p. 277, doi. 10.1007/s00280-014-2498-5
- By:
- Publication type:
- Article
Phase II trial of vatalanib in patients with advanced or metastatic pancreatic adenocarcinoma after first-line gemcitabine therapy (PCRT O4-001).
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 2, p. 379, doi. 10.1007/s00280-014-2499-4
- By:
- Publication type:
- Article
Population pharmacokinetics of trastuzumab emtansine (T-DM1), a HER2-targeted antibody-drug conjugate, in patients with HER2-positive metastatic breast cancer: clinical implications of the effect of covariates.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 2, p. 399, doi. 10.1007/s00280-014-2500-2
- By:
- Publication type:
- Article
Evaluation of the effect of food and ketoconazole on the pharmacokinetics of the smoothened inhibitor PF-04449913 in healthy volunteers.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 2, p. 411, doi. 10.1007/s00280-014-2502-0
- By:
- Publication type:
- Article
Novel DNA methyltransferase-1 (DNMT1) depleting anticancer nucleosides, 4′-thio-2′-deoxycytidine and 5-aza-4′-thio-2′-deoxycytidine.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 2, p. 291, doi. 10.1007/s00280-014-2503-z
- By:
- Publication type:
- Article
Enhanced skin toxicity associated with the combination of clofarabine plus cytarabine for the treatment of acute leukemia.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 2, p. 303, doi. 10.1007/s00280-014-2504-y
- By:
- Publication type:
- Article
Hypothyroidism as a potential biomarker of efficacy of famitinib, a novel VEGFR-2 inhibitor in metastatic breast cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 2, p. 389, doi. 10.1007/s00280-014-2505-x
- By:
- Publication type:
- Article
Comparative pharmacokinetic/pharmacodynamic characterisation of a new pegylated recombinant E. coli l-asparaginase preparation (MC0609) in Beagle dog.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 2, p. 367, doi. 10.1007/s00280-014-2506-9
- By:
- Publication type:
- Article
Influence of genetic polymorphisms of FPGS, GGH, and MTHFR on serum methotrexate levels in Chinese children with acute lymphoblastic leukemia.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 2, p. 283, doi. 10.1007/s00280-014-2507-8
- By:
- Publication type:
- Article
Circulating biomarkers in hepatocellular carcinoma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 2, p. 323, doi. 10.1007/s00280-014-2508-7
- By:
- Publication type:
- Article
Frontline treatment with gemcitabine, oxaliplatin and erlotinib for the treatment of advanced or metastatic pancreatic cancer: a multicenter phase II study of the Hellenic Oncology Research Group (HORG).
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 2, p. 333, doi. 10.1007/s00280-014-2509-6
- By:
- Publication type:
- Article
Impact of patient ethnicity on the metabolic and immunologic effects of PI3K-mTOR pathway inhibition in patients with solid tumor malignancies.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 2, p. 359, doi. 10.1007/s00280-014-2510-0
- By:
- Publication type:
- Article
Evaluation of pharmacokinetics and safety of ponatinib in subjects with chronic hepatic impairment and matched healthy subjects.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 2, p. 341, doi. 10.1007/s00280-014-2511-z
- By:
- Publication type:
- Article
Gastric cancer with para-aortic lymph nodes metastasis: curable dissection possible but be cautiously selected.
- Published in:
- 2014
- By:
- Publication type:
- Letter
In vitro testing of drug combinations employing nilotinib and alkylating agents with regard to pretransplant conditioning treatment of advanced-phase chronic myeloid leukemia.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 2, p. 427, doi. 10.1007/s00280-014-2533-6
- By:
- Publication type:
- Article
Pharmacokinetics of afatinib in subjects with mild or moderate hepatic impairment.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 2, p. 267, doi. 10.1007/s00280-014-2484-y
- By:
- Publication type:
- Article